Publicaciones (43) Publicaciones de MANUEL RODRIGUEZ GARCIA

2024

  1. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

    Journal of Hepatology, Vol. 80, Núm. 2, pp. 232-242

  2. Macro-AST as a cause of hypertransaminasemia: an uncommon entity but it exists

    Revista espanola de enfermedades digestivas, Vol. 116, Núm. 3, pp. 166-167

  3. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology

  4. No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

    Scientific Reports, Vol. 14, Núm. 1

  5. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Journal of Hepatology, Vol. 80, Núm. 1, pp. 73-81

  6. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics

2023

  1. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Liver International, Vol. 43, Núm. 7, pp. 1548-1557

  2. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    The Lancet Gastroenterology and Hepatology, Vol. 8, Núm. 10, pp. 879-907

  3. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  4. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

    Journal of Hepatology

  5. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

    Transplantation, Vol. 107, Núm. 6, pp. 1330-1340

  6. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 8, pp. 594-602

  7. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132

  8. Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 10, pp. 754-763

  9. Prevalence and pattern of alcohol consumption in patients with hepatocellular carcinoma

    Medicina Clinica, Vol. 161, Núm. 2, pp. 49-53

  10. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  11. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

    Digestive Diseases and Sciences, Vol. 68, Núm. 6, pp. 2731-2737

2022

  1. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

    Scientific Reports, Vol. 12, Núm. 1

  2. Disulfiram hepatotoxicity: Report of three cases

    Medicina Clinica

  3. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study

    Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143